全文获取类型
收费全文 | 155656篇 |
免费 | 13042篇 |
国内免费 | 6132篇 |
专业分类
耳鼻咽喉 | 579篇 |
儿科学 | 3455篇 |
妇产科学 | 805篇 |
基础医学 | 10622篇 |
口腔科学 | 737篇 |
临床医学 | 20060篇 |
内科学 | 21233篇 |
皮肤病学 | 557篇 |
神经病学 | 9616篇 |
特种医学 | 7571篇 |
外国民族医学 | 97篇 |
外科学 | 20810篇 |
综合类 | 30532篇 |
现状与发展 | 13篇 |
一般理论 | 1篇 |
预防医学 | 8164篇 |
眼科学 | 1158篇 |
药学 | 15099篇 |
119篇 | |
中国医学 | 7425篇 |
肿瘤学 | 16177篇 |
出版年
2024年 | 395篇 |
2023年 | 2452篇 |
2022年 | 4824篇 |
2021年 | 7133篇 |
2020年 | 6383篇 |
2019年 | 5118篇 |
2018年 | 5119篇 |
2017年 | 5906篇 |
2016年 | 6371篇 |
2015年 | 6274篇 |
2014年 | 11359篇 |
2013年 | 11901篇 |
2012年 | 10244篇 |
2011年 | 10810篇 |
2010年 | 8732篇 |
2009年 | 8033篇 |
2008年 | 7887篇 |
2007年 | 8015篇 |
2006年 | 7379篇 |
2005年 | 6390篇 |
2004年 | 5064篇 |
2003年 | 4373篇 |
2002年 | 3546篇 |
2001年 | 3206篇 |
2000年 | 2607篇 |
1999年 | 2109篇 |
1998年 | 1801篇 |
1997年 | 1716篇 |
1996年 | 1434篇 |
1995年 | 1171篇 |
1994年 | 1039篇 |
1993年 | 783篇 |
1992年 | 738篇 |
1991年 | 612篇 |
1990年 | 561篇 |
1989年 | 467篇 |
1988年 | 408篇 |
1987年 | 345篇 |
1986年 | 307篇 |
1985年 | 351篇 |
1984年 | 268篇 |
1983年 | 164篇 |
1982年 | 201篇 |
1981年 | 183篇 |
1980年 | 177篇 |
1979年 | 126篇 |
1978年 | 84篇 |
1977年 | 77篇 |
1976年 | 53篇 |
1975年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
32.
Whitney S. Brandt Wanpu Yan Jian Zhou Kay See Tan Joseph Montecalvo Bernard J. Park Prasad S. Adusumilli James Huang Matthew J. Bott Valerie W. Rusch Daniela Molena William D. Travis Mark G. Kris Jamie E. Chaft David R. Jones 《The Journal of thoracic and cardiovascular surgery》2019,157(2):743-753.e3
Objective
Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.Methods
Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.Results
In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.Conclusions
Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection. 相似文献33.
Christopher D Hue Frances S Cho Siqi Cao Cameron R ”Dale” Bass David F Meaney Barclay Morrison III 《Journal of cerebral blood flow and metabolism》2015,35(7):1191-1198
Owing to the frequent incidence of blast-induced traumatic brain injury (bTBI) in recent military conflicts, there is an urgent need to develop effective therapies for bTBI-related pathologies. Blood-brain barrier (BBB) breakdown has been reported to occur after primary blast exposure, making restoration of BBB function and integrity a promising therapeutic target. We tested the hypothesis that treatment with dexamethasone (DEX) after primary blast injury potentiates recovery of an in vitro BBB model consisting of mouse brain endothelial cells (bEnd.3). DEX treatment resulted in complete recovery of transendothelial electrical resistance and hydraulic conductivity 1 day after injury, compared with 3 days for vehicle-treated injured cultures. Administration of RU486 (mifepristone) inhibited effects of DEX, confirming that barrier restoration was mediated by glucocorticoid receptor signaling. Potentiated recovery with DEX treatment was accompanied by stronger zonula occludens (ZO)-1 tight junction immunostaining and expression, suggesting that increased ZO-1 expression was a structural correlate to BBB recovery after blast. Interestingly, augmented ZO-1 protein expression was associated with specific upregulation of the α+ isoform but not the α− isoform. This is the first study to provide a mechanistic basis for potentiated functional recovery of an in vitro BBB model because of glucocorticoid treatment after primary blast injury. 相似文献
34.
目的:探析手指钝性离断伤采用断指再植手术治疗的临床效果。方法整群选择2013年6月—2014年6月期间该院收治的手指钝性离断伤患者59例为研究对象,对其临床治疗资料进行回顾性分析。结果该组的59例患者中,术后断指再成活54例,占91.53%,5例失败,占8.47%,其中手指远端坏死3例,占5.08%,2例术后感染,占3.39%。结论临床上给予手指钝性离断伤患者断指再植手术治疗,可以获得较好的效果,有助于恢复患者的手指功能。 相似文献
35.
目的:探讨3D-CRT 低剂量区 V5体积的大小对非小细胞肺癌患者肺功能的影响。方法:收集我院肿瘤科2014年4月~2015年10月收治的46例首次行三维适形放射治疗且顺利完成治疗的非小细胞肺癌患者,对每例患者分别在治疗前以及治疗后的1、3个月进行肺功能检测,分析3D-CRT 低剂量区 V5体积的大小与肺功能变化之间的关系。结果:放疗后1个月的 FEV1%、FVC%值明显高于放疗前且差异均具有显著性。放疗后1个月、3个月的 DLCO%值明显低于放疗前,且放疗前的与放疗后3个月的差异具有显著性;V5≦45%、45%55%三组放疗前后的 FEV1%值和 FVC%值比较差异均不具有显著性。V5≦45%、45%55%三组放疗前后的 DLCO%值均呈逐渐下降趋势,且 V5>55%组的放疗前后 DLCO%值比较差异具有显著性。而 V5≦45%组和45%55%时,DLCO%值降低的趋势更加显著。 相似文献
36.
37.
38.
《Burns : journal of the International Society for Burn Injuries》2022,48(2):345-354
Research supports that people of color in the U.S. have poorer outcomes after burn injury compared to White individuals. The current study sought to explore burn health disparities by testing the relationship between racial and ethnic minority status, a proxy for systemic discrimination due to race and ethnicity, with two key constructs linked to functional outcomes, satisfaction with appearance and social community integration. Participants included 1318 burn survivors from the Burn Model System National Database (mean age = 40.2, SD = 12.7). Participants completed measures of satisfaction with appearance and social community integration at baseline, 6-, 12-, and 24-months after burn injury. Linear regressions revealed that racial and ethnic minority status significantly related to lower satisfaction with appearance and social community integration compared to White individuals at all time points. In addition, satisfaction with appearance continued to significantly relate to greater social community integration even while accounting for race and ethnicity, age, sex, burn size, and physical disability at 6-, 12-, and 24-month time points. Overall, the study supports that racial and ethnic minority burn survivors report greater dissatisfaction with their appearance and lower social community reintegration after burn injury. 相似文献
39.
《Journal of hand therapy》2020,33(1):60-66
Study DesignClinical commentary.Introduction/PurposePain and movement are universally relevant phenomena that influence human experiences in readily observable ways. Improved understanding of pain-movement relationships can guide medical and rehabilitative approaches to recovery and decrease risk of dysfunctional long-term consequences of otherwise normal neuromuscular responses. Therefore, the overall intent of this article is to elucidate the relationships between pain and movement as they relate to clinical decision making.ConclusionsMotor output is highly adaptable, can be influenced by multiple mechanisms at various levels along the nervous system, and may vary between individuals despite similar diagnoses. Therefore, interventions need to be individualized and consider both the types of motor response observed (ie, whether the response is protective or maladaptive), and the patient's acute physical activity tolerance when prescribing exercise/movement. 相似文献
40.